0001209191-19-051655.txt : 20191002 0001209191-19-051655.hdr.sgml : 20191002 20191002161653 ACCESSION NUMBER: 0001209191-19-051655 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190918 FILED AS OF DATE: 20191002 DATE AS OF CHANGE: 20191002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LOVE TED W CENTRAL INDEX KEY: 0001188919 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35935 FILM NUMBER: 191132423 MAIL ADDRESS: STREET 1: C/O GLOBAL BLOOD THERAPEUTICS, INC. STREET 2: 400 EAST JAMIE COURT, SUITE 101 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PORTOLA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001269021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 270 EAST GRAND AVENUE, SUITE 22 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-244-6864 MAIL ADDRESS: STREET 1: 270 EAST GRAND AVENUE, SUITE 22 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2019-09-18 1 0001269021 PORTOLA PHARMACEUTICALS INC PTLA 0001188919 LOVE TED W C/O PORTOLA PHARMACEUTICALS, INC. 270 E. GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 1 0 0 0 /s/ Mike Ouimette, as attorney-in-fact 2019-10-02 EX-24 2 attachment1.htm EX-24 DOCUMENT

POWER OF ATTORNEY
       Know all by these presents, that the undersigned hereby constitutes and
appoints each of John
Moriarty, Mike Ouimette and Sally A. Kay, signing individually, the
undersigned's true and lawful
attorneys-in fact and agents to:
       (1) execute for and on behalf of the undersigned, in the undersigned's
capacity as an
officer, director or beneficial owner of more than 10% of a registered class of
securities of Portola
Pharmaceuticals, Inc. (the "Company"), Forms 3, 4 and 5 (including any
amendments thereto) in
accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended
(the
"Exchange Act") and the rules thereunder and a Form ID, Uniform Application for
Access Codes
to File on EDGAR;
       (2) do and perform any and all acts for and on behalf of the undersigned
that may be
necessary or desirable to execute such Forms 3, 4 or 5 or Form ID (including any
amendments
thereto) and timely file such forms with the United States Securities and
Exchange Commission
and any stock exchange or similar authority; and
       (3) take any other action of any nature whatsoever in connection with the
foregoing
which, in the opinion of such attorney-in-fact, may be of benefit, in the best
interest of, or legally
required by, the undersigned, it being understood that the documents executed by
such attorney-
in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be
in such form and
shall contain such terms and conditions as such attorney-in-fact may approve in
such attorney-in-
fact's discretion.
       The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and
perform any and every act and thing whatsoever requisite, necessary or proper to
be done in the exercise
of any of the rights and powers herein granted, as fully to all intents and
purposes as the undersigned
might or could do if personally present, with full power of substitution or
revocation, hereby ratifying and
confirming all that such attorney-in-fact, or such attorney-in-fact's substitute
or substitutes, shall lawfully
do or cause to be done by virtue of this power of attorney and the rights and
powers herein granted. The
undersigned acknowledges that the foregoing attorneys-in-fact, in serving in
such capacity at the request
of the undersigned, are not assuming, nor is the Company assuming, any of the
undersigned?s
responsibilities to comply with Section 16 of the Exchange Act.
       This Power of Attorney shall remain in full force and effect until the
earliest to occur of (a) the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of
and transactions in securities issued by the Company, (b) revocation by the
undersigned in a signed
writing delivered to the foregoing attorneys-in-fact or (c) as to any
attorney-in-fact individually, until
such attorney-in-fact is no longer employed by the Company or Cooley LLP.
       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of
October 1, 2019.

/s/ Ted W. Love

TED W. LOVE, M.D.
Power of Attorney


117181417 v1